Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/01/29/3228534/0/en/Revolution-Medicines-Doses-First-Patient-in-Clinical-Trial-Evaluating-RMC-5127-a-RAS-ON-G12V-Selective-Inhibitor.html

GLOBENEWSWIRE
29 Jan 2026